SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-18-003305
Filing Date
2018-11-08
Accepted
2018-11-08 16:03:15
Documents
15
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm 8-K 18192
2 PRESS RELEASE sonoma_ex9901.htm EX-99.1 105635
3 PRESENTATION sonoma_ex9902.htm EX-99.2 12768
4 GRAPHIC image_001.jpg GRAPHIC 198990
5 GRAPHIC image_002.jpg GRAPHIC 77696
6 GRAPHIC image_003.jpg GRAPHIC 171028
7 GRAPHIC image_004.jpg GRAPHIC 53053
8 GRAPHIC image_005.jpg GRAPHIC 45762
9 GRAPHIC image_006.jpg GRAPHIC 65589
10 GRAPHIC image_007.jpg GRAPHIC 97197
11 GRAPHIC image_008.jpg GRAPHIC 107591
12 GRAPHIC image_009.jpg GRAPHIC 95742
13 GRAPHIC image_010.jpg GRAPHIC 92942
14 GRAPHIC image_011.jpg GRAPHIC 68651
15 GRAPHIC image_012.jpg GRAPHIC 55303
  Complete submission text file 0001683168-18-003305.txt   1694671
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 181169619
SIC: 2834 Pharmaceutical Preparations